Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Prosorba Column recommended for approval by FDA advisory panel

Nov. 2, 1998

Vertex and HMR initiate phase I clinical trial with HMR-3480/VX-740

Oct. 30, 1998

New COX-2 inhibitor scheduled for FDA advisory committee review in early December

Oct. 30, 1998

Preparation and pharmaceutical formulations of nimesulide choline salt claimed by Dompe

Oct. 27, 1998

Anika receives nonapprovable letter from FDA for Orthovisc

Oct. 22, 1998

Synvisc approved for treatment of osteoarthritis in Argentina and Brazil

Oct. 20, 1998

Meloxicam comes out ahead of NSAIDs in comparative studies evaluating tolerability

Oct. 9, 1998

Leflunomide market introduction announced

Oct. 7, 1998

New agents for cytokine- and/or CAM-mediated disorders disclosed by Pfizer

Oct. 7, 1998

M-5011, a novel NSAID, shown to inhibit vertebral bone loss in arthritic rats

Oct. 6, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...